Insufficient LactationNCT05147987
Improving Lactation Success in Black Mothers of Critically Ill Infants
A study testing Hands free wearable breast pump in people with Insufficient Lactation, run by University of Florida at 1 site in United States.
Trial summary
Racial disparities result in Black infants in the neonatal intensive care unit (NICU) receiving less breast milk (BM) than White and Hispanic infants.1 BM improves infant health yet mothers of critically ill infants produce insufficient amounts to provide these benefits which is likely due to inadequate daily breast… Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Insufficient Lactation
- What is being tested?
- Hands free wearable breast pump
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jan 2022to 15 Feb 2025
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Mothers self-identified as Black
- > 18 years of age
- English speaking
- Stated intent to provide breast milk to her infant
- Rate their level of commitment to pumping breast milk for their infant for at least 3 weeks as 3 or greater or a 1-5 point Likert scale
- State they are available for an approximately 30 minute education session prior to hospital discharge
- Infant not expected to be stable enough to bottle/breastfeed for > 21 days
- Access to a mobile phone and able to download app.
Who cannot join
- Known illicit drug use
- Breast reduction or augmentation
- Positive HIV status
- Infant not expected to live > 7 days following delivery
- Has pacemaker
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Improving Lactation Success in Black Mothers of Critically Ill Infants in the NICU Using Discreet, Hands-free, Wearable Breast Pumps
Racial disparities result in Black infants in the neonatal intensive care unit (NICU) receiving less breast milk (BM) than White and Hispanic infants.1 BM improves infant health yet mothers of critically ill infants produce insufficient amounts to provide these benefits which is likely due to inadequate daily breast pumping frequency. Black mothers face unique challenges to frequent breast pumping including returning to work earlier, working in facilities with inadequate lactation support, and limited privacy for breast pumping at home. Therefore, the objective of this pilot study is to determine the feasibility and potential benefits of using a discreet, hands-free, wearable breast pump with an associated App that tracks pumping frequency and BM production to increase lactation success in Black mothers of infants admitted to the NICU. Specific aims include (1) evaluate the feasibility of a discreet, hands-free, wearable pump in Black mothers of critically ill infants to increase pumping frequency and BM production and (2) assess whether results indicate a signal of effectiveness supporting a subsequent adequately powered randomized clinical trial (RCT). Following delivery, 40 Black mothers of critically ill infants will be randomized to one of two groups. Group 1 will be provided a discreet, hands-free, wearable breast pump with an associated App and Group 2 will be provided a standard mechanical breast pump with no associated App. Results will be used to revise the intervention and study processes and to estimate outcome measurement variability and effect sizes needed for sample size calculations for an adequately powered RCT.
- Conditions
- Insufficient Lactation
- Being tested
- Hands free wearable breast pump
- Medical subject headings
- Lactation Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hands free wearable breast pumpDevice
Use of a supplementary breast pump which can be discreetly worn and is hands free
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | Will be provided a discreet, hands-free, wearable breast pump with an associated App Receives: Device: Hands free wearable breast pump |
| Standard care group | No intervention | Will be provided a standard mechanical breast pump with no associated App. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Participants Acceptance of the Intervention
Survey questions regarding the number of participant acceptance of intervention
Measured: at 20-22 days
Secondary outcomes (4)
Pumped Milk Volume
Volume of Pumped milk volume
Measured: up to 21 days
Days to Secretory Activation
Time from birth to a milk sodium level < 20mMol
Measured: Up to 21 days
Total Pumping Sessions
Total pumping sessions over 21 days
Measured: up to 21 days
Lactation Duration
how long mothers continue lactating
Measured: up to 100 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Dec 2021
- Study start1 Jan 2022
- Primary completion15 Feb 2025
- Study completion15 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Insufficient LactationStudies of the same condition, open and under way.
- More trials run by University of FloridaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Florida
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Leslie Parker, Principal investigator, University of Florida
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05147987
- Sponsor's protocol ID
- IRB202102029
- Status last verified
- Nov 2024
- First submitted
- 8 Nov 2021
- Last updated
- 9 Sep 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No